Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration

Abstract

, and S. Itescu. Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration. Am J Physiol Heart Circ Physiol 287: H525-H532, 2004; 10.1152/ ajpheart.00058.2004.-The primary cardiac response to ischemic insult is cardiomyocyte hypertrophy, which initiates a genetic program culminating in apoptotic myocyte loss, progressive collagen replacement, and heart failure, a process termed cardiac remodeling. Although a few cardiomyocytes at the peri-infarct region can proliferate and regenerate after injury, no approaches are known to effectively induce endogenous cardiomyocytes to enter the cell cycle. We recently isolated, in human adult bone marrow, endothelial progenitor cells, or angioblasts, that migrate to ischemic myocardium, where they induce neovascularization and prevent myocardial remodeling. Here we show that increasing the number of angioblasts trafficking to the infarct zone results in dose-dependent neovascularization with development of progressively larger-sized capillaries. This results in sustained improvement in cardiac function by mechanisms involving protection against apoptosis and, strikingly, induction of proliferation/ regeneration of endogenous cardiomyocytes. Our results suggest that agents that increase myocardial homing of bone marrow angioblasts could effectively induce endogenous cardiomyocytes to enter the cell cycle and improve functional cardiac recovery. stem cells; myocardial remodeling; myocardial infarction AN INTEGRAL COMPONENT of the healing process after a myocardial infarction is compensatory hypertrophy of viable cardiomyocytes at the peri-infarct rim to increase pump function in response to the loss of infarcted tissue (9, 24). However, cardiomyocyte hypertrophy initiates a genetic program that culminates in apoptotic loss of the cardiomyocytes, expansion of the initial infarct area, progressive collagen replacement, and heart failure (1,5,19,20), a process termed cardiac remodeling. Pharmacological means to prevent cardiomyocyte hypertrophy remain the mainstay of postinfarct therapy to prevent remodeling and heart failure. Recent observations have suggested that a second compensatory response of viable cardiomyocytes at the peri-infarct region is to proliferate and regenerate after injury (3, 7). Although cardiomyocyte regeneration can be accomplished by providing exogenous precursors, for example, from the bone marrow (17), no approaches are known to effectively induce endogenous cardiomyocytes to enter the cell cycle.We recently put forward the hypothesis that hypertrophied cardiomyocytes undergo apoptosis, because the endogenous capillary network cannot provide the compensatory increase in perfusion required for cell survival (12). Vascular network formation is the result of a complex process that begins in the prenatal period with induction of vasculogenesis by hemangioblasts, cells derived from the human ventral aorta that give rise to endothelial and hematopoietic elements (4, 6, 10, 13). Postnatal vasculogenesis occurs via pathways ...

Immune system in renal injury and repair: Burning the candle from both ends?

“…In a model of myocardial infarction in bone marrow transplanted mice, histological analysis showed donor-derived endothelial cells in areas of neovascularization at the border zone of the infarct (73). Recently, the degree of myocardial neovascularization and the level of protection against ischemia-induced cardiomyocyte apoptosis in rats have been shown to depend on the absolute numbers of injected angioblasts (74). These experimental data have been strongly supported by clinical observations.…”

Intracoronary Stem Cell Infusion in Heart Transplant Candidates

“…Exciting results of the experimental studies have led to clinical studies which demonstrated benefit of the stem cells on left ventricular functions after acute myocardial infarction or ischemic cardiomyopathy (Chachques et al 2004;Schuster et al 2004;Ince et al 2005). Being accepted as an effective and safe way of performing stem cells into infarcted myocardial region, intracoronary infusion has become a preferable route in particularly acute MI patients (Chen et al 2004;Fernandez-Aviles et al 2004).…”

Cell transplantation for cardiac regeneration: where do we stand?

“…This effect was dose dependent and caused regeneration of new myocardium by inducing cardiomyocyte cycling. 34 However, several authors have questioned this process of direct incorporation of BMCs into the vascular wall and instead proposed a different mechanism. 35 The development of new vasculature or collateral vessels could be induced by pro-arteriogenic factors secreted by the transplanted BMCs, possibly by the presence of large numbers of monocytes in these fractions.…”